Therapeutic indications

Avacopan is indicated for:

Granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA)

Population group: both men and women, only adults (18 years old or older)

Avacopan, in combination with a rituximab or cyclophosphamide regimen, is indicated for the treatment of adult patients with severe, active granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA).

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines